Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies

A question is raised about an increased risk of severe infection from the use of biological drugs in patients with rheumatoid arthritis. This systematic review of observational studies aimed at assessing the risk of severe infection associated with the use of anakinra, rituximab, and abatacept in pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista Brasileira de Reumatologia 2016-11, Vol.56 (6), p.543-550
Hauptverfasser:	Cabral, Vanderlea Poeys, Andrade, Carlos Augusto Ferreira de, Passos, Sonia Regina Lambert, Martins, Maria de Fátima Moreira, Hökerberg, Yara Hahr Marques
Format:	Artikel
Sprache:	eng
Schlagworte:	Abatacept Anti-rheumatic drugs/adverse effects Antirheumatic Agents - adverse effects Antirheumatic Agents - therapeutic use Antirreumáticos/efeitos adversos Arthritis, Rheumatoid - drug therapy Artrite reumatoide/terapia Biological therapy/adverse effects Humans Immunologic Factors - adverse effects Immunologic Factors - therapeutic use Infection Infecção Interleukin 1 Receptor Antagonist Protein Review of literature as topic Revisão de literatura como assunto Rheumatoid arthritis/therapy Rituximab Terapia biológica/efeitos adversos
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!